SG11201602585XA - Methods of detection and removal of rhabdoviruses from cell lines - Google Patents

Methods of detection and removal of rhabdoviruses from cell lines

Info

Publication number
SG11201602585XA
SG11201602585XA SG11201602585XA SG11201602585XA SG11201602585XA SG 11201602585X A SG11201602585X A SG 11201602585XA SG 11201602585X A SG11201602585X A SG 11201602585XA SG 11201602585X A SG11201602585X A SG 11201602585XA SG 11201602585X A SG11201602585X A SG 11201602585XA
Authority
SG
Singapore
Prior art keywords
rhabdoviruses
removal
detection
methods
cell lines
Prior art date
Application number
SG11201602585XA
Inventor
Joel Haynes
Original Assignee
Takeda Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Vaccines Inc filed Critical Takeda Vaccines Inc
Publication of SG11201602585XA publication Critical patent/SG11201602585XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/205Rhabdoviridae, e.g. rabies virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • C12N7/045Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20051Methods of production or purification of viral material
    • C12N2760/20052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
SG11201602585XA 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines SG11201602585XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361886438P 2013-10-03 2013-10-03
PCT/US2014/059060 WO2015051255A1 (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines

Publications (1)

Publication Number Publication Date
SG11201602585XA true SG11201602585XA (en) 2016-05-30

Family

ID=52779185

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10202107054TA SG10202107054TA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines
SG10201802772YA SG10201802772YA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines
SG11201602585XA SG11201602585XA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SG10202107054TA SG10202107054TA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines
SG10201802772YA SG10201802772YA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines

Country Status (9)

Country Link
US (4) US10501500B2 (en)
EP (1) EP3052631B1 (en)
JP (6) JP2016533172A (en)
KR (2) KR102474663B1 (en)
CN (1) CN106103720A (en)
AU (3) AU2014329403B2 (en)
CA (1) CA2926225A1 (en)
SG (3) SG10202107054TA (en)
WO (1) WO2015051255A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140200831A1 (en) * 2011-01-28 2014-07-17 Schlumberger Technology Corporation Pipe Damage Interpretation System
JP2016533172A (en) 2013-10-03 2016-10-27 タケダ ワクチン,インコーポレイテッド Methods for detecting and removing rhabdoviruses from cell lines
WO2016115484A1 (en) * 2015-01-16 2016-07-21 Takeda Vaccines, Inc. Detection of particle-contained reverse transcriptase activity
JP6814739B2 (en) 2015-03-05 2021-01-20 ベーリンガー・インゲルハイム・アニマル・ヘルス・ユーエスエー・インコーポレイテッドBoehringer Ingelheim Animal Health Usa Inc. Marker system, especially for baculovirus-expressing subunit antigen
CN104962580B (en) * 2015-06-30 2018-04-27 浙江大学 A kind of recombinant plant Rhabdovirus vector and its construction method
WO2017075627A1 (en) 2015-11-01 2017-05-04 Glycobac, Llc Virus-free cell lines and methods for obtaining same
CN109182277B (en) * 2018-09-07 2021-05-07 中国水产科学研究院长江水产研究所 Monopterus albus rhabdovirus CrERV and RT-PCR detection primer and application
EP4100420A1 (en) 2020-02-06 2022-12-14 Boehringer Ingelheim Vetmedica GmbH Polypeptides useful for detecting anti-rhabdovirus antibodies
CN115052974A (en) * 2020-02-10 2022-09-13 生物马林药物股份有限公司 Virus-free cell culture
CN114686599A (en) * 2020-12-30 2022-07-01 北京五加和基因科技有限公司 Method and kit for quantitatively detecting DNA residual content of host insect cell
EP4340874A1 (en) 2021-05-21 2024-03-27 Takeda Vaccines, Inc. Solid composition, freeze-drying method and glass vial

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
JP3500602B2 (en) 1998-03-31 2004-02-23 株式会社エスキューブ Anti-theft tag
ES2626268T3 (en) * 2002-09-11 2017-07-24 Chugai Seiyaku Kabushiki Kaisha Protein Purification Method
DK2601969T3 (en) 2006-09-29 2016-04-18 Takeda Vaccines Inc Norovirus vaccine formulations
KR101576219B1 (en) 2007-03-14 2015-12-10 다케다 백신즈 인코포레이티드 Virus like particle purification
CN104740624B (en) 2007-09-18 2018-04-24 武田疫苗股份有限公司 Assign the vaccine of the protective immune response for norovirus
PL2324113T3 (en) 2008-08-08 2018-08-31 Takeda Vaccines, Inc. Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
TW201030016A (en) * 2008-10-20 2010-08-16 Abbott Lab Antibodies that bind to IL-18 and methods of purifying the same
US9056896B2 (en) * 2009-03-27 2015-06-16 Asahi Kasei Medical Co., Ltd. Method for removing viruses from high concentration monoclonal antibody solution
PL3299030T3 (en) 2011-07-11 2022-12-05 Takeda Vaccines, Inc. Parenteral norovirus vaccine formulations
CN102605106B (en) * 2012-03-29 2013-09-04 浙江省检验检疫科学技术研究院 Triple-fluorescence PCR (Polymerase Chain Reaction) detection method and kit for Nosema bombycis (Nb), Bombyx mori Nuclear Polyhedrosis Virus (BmNPV) and Bombyx mori Densovirus (BmDNV), as well as primers and probes
JOP20130186B1 (en) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc Purification of virus like particles
JP2016533172A (en) 2013-10-03 2016-10-27 タケダ ワクチン,インコーポレイテッド Methods for detecting and removing rhabdoviruses from cell lines

Also Published As

Publication number Publication date
AU2020294216B2 (en) 2022-11-24
JP2022009010A (en) 2022-01-14
US10501500B2 (en) 2019-12-10
JP2024050747A (en) 2024-04-10
CA2926225A1 (en) 2015-04-09
AU2020294216A1 (en) 2021-01-28
WO2015051255A1 (en) 2015-04-09
US20220213150A1 (en) 2022-07-07
JP2016533172A (en) 2016-10-27
US20160244487A1 (en) 2016-08-25
JP2020036613A (en) 2020-03-12
EP3052631B1 (en) 2019-08-07
KR20210154988A (en) 2021-12-21
SG10202107054TA (en) 2021-08-30
AU2014329403B2 (en) 2020-10-08
AU2022259826A1 (en) 2023-01-19
CN106103720A (en) 2016-11-09
SG10201802772YA (en) 2018-05-30
AU2014329403A1 (en) 2016-05-05
KR102649950B1 (en) 2024-03-22
EP3052631A4 (en) 2017-06-14
KR102474663B1 (en) 2022-12-07
EP3052631A1 (en) 2016-08-10
US11286282B2 (en) 2022-03-29
US20230303633A1 (en) 2023-09-28
US20200190146A1 (en) 2020-06-18
JP2023024506A (en) 2023-02-16
KR20160062049A (en) 2016-06-01
JP7191175B2 (en) 2022-12-16
JP2023126495A (en) 2023-09-07

Similar Documents

Publication Publication Date Title
HK1219975A1 (en) Cell lines for virus production and methods of use
HK1217539A1 (en) Systems and methods for detection of cells using engineered transduction particles
HK1220800A1 (en) Particle detection system and related methods
SG10202107054TA (en) Methods of detection and removal of rhabdoviruses from cell lines
EP2971279A4 (en) Methods and devices for high throughpout purification
EP2965479A4 (en) Methods and systems for enhanced detection of e-navigation messages
GB201319105D0 (en) Detection apparatus and method
ZA201500394B (en) Methods of handling avocados and system
HK1215416A1 (en) Separation device and separation method
IL244274B (en) Device and methods of using device for detection of hyperammonemia
HK1224256A1 (en) Object detection system and method for object detection system
GB201315185D0 (en) Location detection system and method
EP2998901A4 (en) Unauthorized-access detection system and unauthorized-access detection method
EP2948566A4 (en) Chromophore-based characterization and detection methods
GB2513304B (en) Peripheral apparatus and method of construction
HRP20181974T1 (en) Method of and system for gaming
EP2971257A4 (en) Systems and methods of protecting electrolysis cell sidewalls
IL245272A0 (en) Pif-transfected cells and methods of use
GB201319099D0 (en) Detection apparatus and method
HK1207449A1 (en) Methods and apparatus for efficient execution of modules
IL227948A (en) Methods of desalination and rinsing and systems therefor
IL240309B (en) System and method of processing produce
SG11201605386TA (en) Uni-directional rigidifier and method
GB201306810D0 (en) Methods of cell separation
GB2513388B (en) Improved dock bumper and method of replacement